Clinical Trials Directory

Trials / Sponsors / New Mexico Cancer Research Alliance

New Mexico Cancer Research Alliance

Academic / Other · 72 registered clinical trials4 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingProgestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window
Endometrial Endometrioid Adenocarcinoma, Endometrial Hyperplasia
Phase 22026-03-01
Active Not RecruitingPhysical Activity Intervention for the Improvement of Pain in Young, Hispanic Breast Cancer Survivors
Breast Cancer
N/A2023-10-20
RecruitingEngagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
Malignant Neoplasm
N/A2022-03-22
CompletedFood Insecurity in Oncology
Food Insecurity, Cancer
N/A2021-08-30
CompletedEnhancing Cancer Prevention and Control Pathways-Native Health Initiative
Cancer, Breast, Cancer, Colon, Cancer, Cervix
N/A2021-06-01
Active Not RecruitingMonitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscop
HER2 Negative Breast Cancer
2018-04-16
CompletedBreast Cancer Screening for Underserved Women: Comparing Outcomes and Lowering Recall Rates With 3D- vs. 2D-ma
Breast Cancer Screening
2016-09-22
TerminatedAcute Lymphoblastic Leukemia Therapies Informed by Genomic Analyses
Leukemia, Acute Lymphoblastic
N/A2016-07-28
CompletedOmega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel
Breast Cancer, Ovarian Neoplasm, Pain
N/A2016-05-24
CompletedWhole Brain Radiation Using IMRT for Patients With Brain Metastases
Neoplasm Metastasis, Central Nervous System Metastases
N/A2016-03-09
Active Not RecruitingPARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer
Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
Phase 1 / Phase 22016-02-23
RecruitingTotal Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
Cancer, Cancer Risk
2016-01-27
RecruitingLaboratory Study of Cancer & Immune Cells in Ascites Fluid of Ovarian Cancer Patients to Test Alternative Ther
Ovarian Cancer
2015-12-02
WithdrawnIrinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract Cancers
Biliary Tract Cancer
Phase 22015-11-01
CompletedEvaluation of GTPase Inhibition by Post-operative Intravenous Ketorolac in Ovarian Cancer Patients
Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer
N/A2015-10-29
CompletedMathematical Modeling to Predict Response to Neoadjuvant Chemotherapy in Breast Cancer
Breast Cancer
2015-06-02
CompletedExosome Testing as a Screening Modality for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinom
Oropharyngeal Cancer
2015-02-25
CompletedGenome Sequencing of Human Cancer Tissues
Cancer
N/A2015-01-01
TerminatedPhase I Trial of Everolimus, Pomalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myel
Multiple Myeloma in Relapse
Phase 12014-07-01
TerminatedFeasibility of Thioridazine as a Mobilizing Agent for CD34+ Hematopoietic Progenitor Cells
Healthy Subjects
EARLY_Phase 12013-06-01
TerminatedA Combination of Pazopanib and Carboplatin in Advanced Solid Malignancies
Cancer, Metastatic
Phase 12012-08-01
TerminatedIR-guided Ablation (IRGA) Combined With Stereotactic Ablative Radiation (SABR) for Large Lung Tumors
Recurrent Non-small Cell Lung Cancer
Phase 12012-07-01
CompletedINST 1204: PIK3CA Mutations as Biomarkers for Metastasis in Colon Cancer
Colon Cancer
2012-05-22
TerminatedIrinotecan for Previously Treated, Advanced, Non-Small Cell Lung Cancer
Non-small Cell Lung Cancer
Phase 1 / Phase 22012-04-01
CompletedAvailability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer
EARLY_Phase 12012-03-01
WithdrawnMetformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer
Prostate Cancer
Phase 22011-06-01
CompletedExpression & Epigenetic Silencing of MicroRNA for Predicting Therapeutic Response and Prognosis of HPV-negativ
Head and Neck Squamous Cell Carcinoma
2010-12-17
CompletedPilot Study of Raltegravir and Cisplatin in Squamous Cell Carcinoma of Head and Neck
Head and Neck Cancer
EARLY_Phase 12010-12-01
TerminatedStudy of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer
Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Carcinoma
Phase 12010-09-01
TerminatedVelcade and Sorafenib in Unresected or Metastatic Renal Cell Carcinoma
Metastatic Renal Cell Carcinoma
Phase 22010-04-01
TerminatedTemsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Ca
Squamous Cell Carcinoma
Phase 22009-12-01
CompletedPelvic Floor Muscle Training in Treating Urinary Incontinence in Gynecologic Cancer Survivors
Cervical Cancer, Endometrial Cancer, Ovarian Epithelial Cancer
N/A2009-11-01
TerminatedPhase I/II Study of Irinotecan and Temsirolimus in Patients With Refractory Sarcomas
Sarcoma
Phase 12009-10-01
TerminatedSorafenib With Capecitabine for Patients With Measurable Hepatocellular Carcinoma
Hepatocellular Carcinoma
Phase 22009-09-01
WithdrawnA Study of Imatinib and Valproic Acid in Patients With Chronic Myelogenous Leukemia (CML)
Chronic Myelogenous Leukemia
Phase 22009-09-01
TerminatedCarboplatin, Paclitaxel, and Temozolomide for Patients With Metastatic Melanoma
Melanoma
Phase 22009-08-01
CompletedStudy of Gleevec and Weekly Paclitaxel in Patients Aged 70 or Older With Advanced Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Phase 22009-08-01
TerminatedStudy of Stereotactic Body Radiation Therapy Using Tomotherapy for Metastatic Tumors to the Liver
Liver Cancer
Phase 22009-06-01
TerminatedComparison of Standard of Care or Treatment on Protocol
Stomach Cancer, Esophageal Cancer, Bladder Cancer
N/A2009-03-01
TerminatedUltraviolet Light Exposure and Immunosuppression in Cutaneous Melanoma
Melanoma
2009-01-01
TerminatedCompassionate Use of Mifepristone in Brain/Nervous System and Other Cancers
Cancer
N/A2008-11-01
CompletedThe Response of Serum 25-Hydroxyvitamin D to Incidental Ultraviolet Light Exposure
Melanoma
2008-11-01
TerminatedPhase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight
Advanced Cancer
Phase 22008-11-01
CompletedCombination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer
Pancreatic Cancer
Phase 22008-10-01
TerminatedBiomarker Study of Neoadjuvant Vitamin E in Patients With Locally Treatable Prostate Cancer
Prostate Cancer
Phase 32008-09-01
CompletedPhase I and Pharmacology Study of Camptothecin-20-O-Propionate Hydrate (CZ48) in Patients With Solid Tumors or
Advanced Solid Tumors, Lymphomas
Phase 12008-09-01
CompletedUse of Hydralazine and Valproic Acid in Advanced Solid Tumor Malignancies
Lung Cancer
Phase 12008-07-01
CompletedA Phase 1 Protocol of 5-Azacytidine and Erlotinib in Advanced Solid Tumor Malignancies
Advanced Solid Tumor Malignancies
Phase 12008-06-01
CompletedPhase II Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Tumors of the Lung
Lung Cancer, Non Small Cell Lung Cancer, Solid Tumors
N/A2008-01-01
TerminatedGemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree Cancers
Hepatocellular Carcinoma, Cholangiocellular Carcinoma, Cholangiocarcinoma of the Extrahepatic Bile Duct
Phase 22007-08-01
TerminatedObservational Study of Best Supportive Care With or Without Surgery, Chemo or Radiotherapy in Pts With Carcino
Lung Cancer
2007-07-01
CompletedStudy of Bevacizumab/Doxil in Treatment of Platinum-Resistant/Refractory Ovarian Cancer (CA)
Ovarian Cancer
Phase 22007-03-01
TerminatedErlotinib and Standard Platinum-Based Chemotherapy for Newly Diagnosed, Advanced Non-Small Cell Carcinoma of t
Carcinoma, Non-Small-Cell Lung
Phase 22006-07-01
CompletedA Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patie
Cancer
Phase 32006-07-01
CompletedExpanded Breast Cancer Registry and Tissue Repository
Breast Cancer
2006-02-16
CompletedClinical Predictors of Survival in Cancer Patients With Metastatic Solid Tumors
Cancer
2006-02-01
WithdrawnDifferences in Trends Malignant Germ Cell Tumors in Males and Females: A SEER Population-based Study
Cancer
2006-01-01
WithdrawnTrends in Incidence and Survivals for Ovarian Germ Cell Tumors: A 27-Year Population-Based Study
Ovarian Cancer
2005-12-01
CompletedPhase IB Study of Gemcitabine, Docetaxel and Bevacizumab in Patients With Soft Tissue Sarcoma
Sarcoma
Phase 12005-11-01
TerminatedProstate Cancer Diagnosis Through NMR Spectroscopy of Semen and Prostatic Secretions
Prostate Cancer
2005-10-01
CompletedGemcitabine and Oxaliplatin for Hepatocellular Carcinoma With Platelet Counts Greater Than 100,000 Per Microli
Liver Cancer
Phase 22005-10-01
TerminatedChart Review of Treatments Received by Patients Diagnosed With Soft Tissue Sarcoma
Sarcoma
2005-08-01
TerminatedCombination of Oxaliplatin, Capecitabine, and Celecoxib With Concurrent Radiation for Rectal Cancer
Rectal Cancer
Phase 22005-04-01
CompletedComparison of Aprepitant Versus Gabapentin in the Prevention of Delayed Nausea and Vomiting
Cancer
Phase 22004-12-01
TerminatedStudy: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic Approach
Non-Hodgkin's Lymphoma, Cancer
Phase 22004-10-01
CompletedClinical Benefit of Topoisomerase Downregulation
Ovarian Cancer
Phase 12004-05-01
CompletedA Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail Gleevec
Leukemia, Other, Cancer
Phase 22004-04-01
CompletedGene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherap
Colonic Diseases, Cancer
N/A2004-04-01
CompletedCombination Paclitaxel, Carboplatin and Temozolomide
Lung Diseases, Cancer
Phase 12003-11-01
CompletedA Phase III Randomized Trial Assessing the Utility of a Test Dose Program With Taxanes
Supportive, Ill-defined Sites
Phase 32002-06-01
CompletedCombination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced o
Kidney, Cancer
Phase 1 / Phase 22000-09-01
No Longer AvailableCompassionate Use of BYL 719 Alpelisib
Lymphangioma